Literature DB >> 29969527

Folate-producing lactic acid bacteria reduce inflammation in mice with induced intestinal mucositis.

R Levit1, G Savoy de Giori1,2, A de Moreno de LeBlanc1, J G LeBlanc1.   

Abstract

AIM: To evaluate two folate-producing strains, Streptococcus (Strep.) thermophilus CRL 808 and Strep. thermophilus CRL 415, against chemically induced mucositis in mice. METHODS AND
RESULTS: In vitro assays with Caco-2 cells were performed to evaluate the effect of the bacteria in the presence of 5-fluorouracil (5-FU). For in vivo studies, mice were daily injected with 5-FU to induce intestinal mucositis (IM) and orally administered with folate-producing strains during 6 days. Clinical symptoms, histological parameters and cytokine profiles were assessed. The results showed that Strep. thermophilus CRL 808 increased the cytotoxicity of 5-FU against Caco-2 cells. Administration of this strain in mice with chemically induced IM resulted in a reduction in diarrhoea score and restoration of the intestinal architecture. Cytokine analysis showed that the anti-inflammatory effect by the bacterium is not associated with an immune mechanism. Regarding Strep. thermophilus CRL 415, no improvements were observed in any of the parameters evaluated.
CONCLUSION: The administration of the folate-producing Strep. thermophilus CRL 808 has the potential to prevent IM induced by 5-FU in mice. SIGNIFICANCE AND IMPACT OF THE STUDY: Folate-producing LAB could be used in chemotherapy patients to reduce the symptoms of IM, improve their nutritional status and increase the effectiveness of 5-FU.
© 2018 The Society for Applied Microbiology.

Entities:  

Keywords:  5-fluorouracil; chemotherapy; folate; inflammation; lactic acid bacteria; mucositis; probiotic

Mesh:

Substances:

Year:  2018        PMID: 29969527     DOI: 10.1111/jam.14038

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  5 in total

Review 1.  Application of vitamin-producing lactic acid bacteria to treat intestinal inflammatory diseases.

Authors:  Jean Guy LeBlanc; Alejandra de Moreno de LeBlanc; Romina Levit; Graciela Savoy de Giori
Journal:  Appl Microbiol Biotechnol       Date:  2020-02-28       Impact factor: 4.813

2.  The genomic basis of the Streptococcus thermophilus health-promoting properties.

Authors:  Emeline Roux; Aurélie Nicolas; Florence Valence; Grégoire Siekaniec; Victoria Chuat; Jacques Nicolas; Yves Le Loir; Eric Guédon
Journal:  BMC Genomics       Date:  2022-03-16       Impact factor: 3.969

3.  Three important short-chain fatty acids (SCFAs) attenuate the inflammatory response induced by 5-FU and maintain the integrity of intestinal mucosal tight junction.

Authors:  Xi Yue; Sun Wen; Ding Long-Kun; Yan Man; Sun Chang; Zhang Min; Li Shuang-Yu; Qian Xin; Ma Jie; Wu Liang
Journal:  BMC Immunol       Date:  2022-04-21       Impact factor: 3.594

Review 4.  Vitamin-Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis.

Authors:  Zihan Zhai; Wenxiao Dong; Yue Sun; Yu Gu; Jiahui Ma; Bangmao Wang; Hailong Cao
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

Review 5.  The Role of Methyl Donors of the Methionine Cycle in Gastrointestinal Infection and Inflammation.

Authors:  Joseph A Vaccaro; Saleh A Naser
Journal:  Healthcare (Basel)       Date:  2021-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.